Newsroom

Sorted by: Latest

-

DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that company management will participate in three upcoming investment bank conferences. Details TD Cowen 46th Annual Healthcare Conference Boston, Massachusetts  Fireside chat with Rick Pauls, CEO, and Julie Krop, M.D., Chief Medical Officer, on Monday, Mar...
-

Organon与Sebela Pharmaceuticals达成MIUDELLA®无激素宫内节育器授权协议

新泽西州泽西市--(BUSINESS WIRE)--(美国商业资讯)-- Organon (NYSE: OGN)是一家全球性医疗保健公司,其使命是提供有影响力的药物和解决方案,以改善人们的日常健康。公司今日宣布已与Sebela Pharmaceuticals达成协议,获得其无激素含铜宫内节育器(IUD)避孕药具MIUDELLA的全球独家授权。本次交易的生效须经《哈特-斯科特-罗迪诺反托拉斯改进法》审核,并获得美国食品药品管理局(FDA)对MIUDELLA替代供应链主体的批准,以及满足若干其他条件。 MIUDELLA是近40年来美国获批的首款无激素含铜IUD,与Organon的商业化能力形成互补,将进一步推动Organon打造满足女性多样化生殖健康需求的产品组合的承诺。MIUDELLA于2025年2月24日获FDA批准,用于育龄女性避孕,有效期最长可达三年,目前尚未上市销售。MIUDELLA为寻求长效、可逆、无激素避孕方式的女性提供了额外选择。MIUDELLA采用独特的柔性支架和全预装置入器,置入管直径仅3.7毫米,细小且呈锥形。1 根据协议条款,Organon将在交易完成时支付2750...
-

Tyler Technologies to Participate in March Investor Conferences

PLANO, Texas--(BUSINESS WIRE)--Tyler Technologies will participate in four investor conferences in March 2026....
-

Miami Freedom Park Selects Evolv Technology for All Guest Ingress Screening at New World-Class Stadium

WALTHAM, Mass.--(BUSINESS WIRE)--Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced that Evolv Express® has been selected for use stadium-wide at Inter Miami CF's new home located at Miami Freedom Park. Evolv Express Gen2 systems will be installed at the new 25,000-seat Florida stadium, which is slated to open on April 4, 2026. Evolv Express was designed to allow people to mo...
-

Virewirx Awarded $1.9M Small Business Innovation Research (SBIR) Contract from Office of the Under Secretary of War (OUSW)

SAN DIEGO--(BUSINESS WIRE)--Virewirx has been awarded a Phase II $1.9 million Small Business Innovation Research (SBIR) OUSW (R&E) FutureG contract from the Office of the Under Secretary of War (OUSW) to develop an advanced 5G system designed to perform reliably in challenging Radio Frequency (RF) environments. This breakthrough technology will enable mission-critical communications in previously impossible environments, ensuring warfighters maintain connectivity for coordination, safety, a...
-

Terreno Realty Corporation Announces Leases in Redondo Beach, CA

BELLEVUE, Wash.--(BUSINESS WIRE)--Terreno Realty Corporation Announces Leases in Redondo Beach, CA...
-

Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (the “Company” or “Allurion”), a pioneer in metabolically healthy weight loss, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,659,565 shares of common stock, issued by the Company on January 27, 2025 (the “January 2025 Warrants”), February 20, 2025 (the “February 2025 Warrants”) and November 12, 2025 (the “November 2025 Wa...
-

McLane Company Unveils New McLane Fresh Products at Convenience Retailing University 2026

TEMPLE, Texas--(BUSINESS WIRE)--McLane Company unveils new McLane Fresh products at Convenience Retailing University 2026....
-

Northwell Health’s Gun Violence Prevention Forum: Spotlighting progress

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--Last year, the United States saw some of the lowest levels of gun violence on record, but there is more work to be done. As part of Northwell Health’s Raise Health series – which convenes bold thinkers twice a year to spark dialogue and drive action on today’s most pressing health care challenges – the spring 2026 Gun Violence Prevention Forum will bring together leaders from industry, health care, science and the community to highlight progress and acceler...
-

Workiva to Present at Upcoming Investor Conferences

NEW YORK--(BUSINESS WIRE)--Workiva Inc. (NYSE:WK), a leading, AI-powered platform for trust, transparency, and accountability, today announced its participation at the following events: Raymond James 47th Annual Institutional Investors Conference: Barbara Larson, Chief Financial Officer, and Mike Rost, Chief Strategy Officer, will present on March 2, 2026 at 9:15 a.m. Eastern Time. Morgan Stanley Technology, Media & Telecom Conference: Julie Iskow, President and Chief Executive Officer, wil...